SEC Comment Letter 0000000000-24-011469 to BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
BIORA THERAPEUTICS, INC. (BIOR) (CIK 0001580063)
Date: Oct. 9, 2024 · CIK: 0001580063 · Accession: 0000000000-24-011469
AI Filing Summary & Sentiment
Letter
October 9, 2024 Eric d'Esparbes Chief Financial Officer Biora Therapeutics, Inc. 4330 La Jolla Village Drive, Suite 300 San Diego, CA 92122 Re:Biora Therapeutics, Inc. Preliminary Proxy Statement on Schedule 14A Filed September 3, 2024 Dear Eric d'Esparbes: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Aaron Briggs
Show Raw Text
October 9, 2024
Eric d'Esparbes
Chief Financial Officer
Biora Therapeutics, Inc.
4330 La Jolla Village Drive, Suite 300
San Diego, CA 92122
Re:Biora Therapeutics, Inc.
Preliminary Proxy Statement on Schedule 14A
Filed September 3, 2024
Dear Eric d'Esparbes:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Aaron Briggs